Often, patients who live with Inflammatory Bowel Disease (IBD) do not respond to conventional drugs and are offered to participate in clinical trials for new treatments. When this happens, patients tend to have doubts and may feel scared because they do not have enough information about the process. This was the case for Tina Aswani Omprakash, IBD patient, patient thought leader, and award-winning author of the blog ´Own Your Crohn’s´, when she was offered to participate in a clinical trial.
Aswani Omprakash talked about her experience from having participated in two clinical trials during the online debate ´IBD & Tea,´ streamed live on our Twitter account on the 25th of November. She was accompanied by IBD medical expert Prof. Fernando Gomollón from the Clinical Hospital of Zaragoza, Spain and Prof. Alan Boyd, our project’s resident regulatory expert and director/founder of Boyd Consultants. The event, moderated by Kira Keini, from the science communication company and our communication partner, Scienseed, has been watched more than 700 times so far.
To read more, please visit: https://newdeal-project.eu/2020/12/ibd-tea-what-patients-want-to-know-when-it-comes-to-a-clinical-trial/
